These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 4122738)

  • 41. Basic mechanisms of chemotherapy.
    Mitchison DA
    Chest; 1979 Dec; 76(6 Suppl):771-81. PubMed ID: 92392
    [No Abstract]   [Full Text] [Related]  

  • 42. Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--fifth investigation. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
    Tubercle; 1970 Jun; 51(2):123-51. PubMed ID: 4099678
    [No Abstract]   [Full Text] [Related]  

  • 43. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

  • 44. 180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
    Jittinandana A; Kecharanandana P; Payanandana W; Daramas M
    J Med Assoc Thai; 1988 May; 71(5):238-43. PubMed ID: 2456361
    [No Abstract]   [Full Text] [Related]  

  • 45. The John Barnwell Lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis.
    Fox W
    Am Rev Respir Dis; 1968 May; 97(5):767-90. PubMed ID: 4171718
    [No Abstract]   [Full Text] [Related]  

  • 46. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
    Tubercle; 1975 Jun; 56(2):81-96. PubMed ID: 1103400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lomefloxacin in complex treatment of acute progressive form of pulmonary tuberculosis].
    Sokolova GB; Kunichan AD; Koriakin VA; Lazareva IaV
    Antibiot Khimioter; 1998; 43(10):10-2. PubMed ID: 9825102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Controlled clinical trial comparing a 6-month and a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Algerian working group/British Medical Research Council cooperative study.
    Am Rev Respir Dis; 1984 Jun; 129(6):921-8. PubMed ID: 6375490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative studies on various antituberculosis chemotherapies--from the results of the Tuberculosis Research Committee (Ryoken).
    Gomi J
    Jpn J Tuberc; 1966 Dec; 13():96-105. PubMed ID: 4166383
    [No Abstract]   [Full Text] [Related]  

  • 50. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W
    Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. East African and British Medical Research Councils.
    Lancet; 1978 Aug; 2(8085):334-8. PubMed ID: 79708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162
    [No Abstract]   [Full Text] [Related]  

  • 53. A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation.
    Am Rev Respir Dis; 1972 Jul; 106(1):1-22. PubMed ID: 4624794
    [No Abstract]   [Full Text] [Related]  

  • 54. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1985 Aug; 132(2):374-8. PubMed ID: 2862820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
    Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-course chemotherapy for pulmonary tuberculosis with a rifampicin-isoniazid-pyrazinamide combination tablet.
    Cowie RL; Brink BA
    S Afr Med J; 1990 Apr; 77(8):390-1. PubMed ID: 2184527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 59. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 60. Practical application of short-course (6 month) regimens of chemotherapy for pulmonary tuberculosis in Kenyan nomads.
    Aluoch JA
    East Afr Med J; 1979 Mar; 56(3):121-6. PubMed ID: 487976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.